EPO is approved for the correction of anemia in patients with chronic renal failure, and its use in renal anemia eliminates the need for red cell transfusions, alleviates the symptoms of anemia, improves survival, reduces cardiovascular morbidity, and enhances the quality of life [6, 7]. Here, EPO is linked to chronic kidney disease.